Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder

被引:14
|
作者
Klein, E
Zinder, O
Colin, V
Zilberman, I
Levy, N
Greenberg, A
Lenox, RH
机构
[1] RAMBAM MED CTR,LAB CLIN BIOCHEM,HAIFA,ISRAEL
[2] TECHNION IIT,RAPPAPORT FAC MED,HAIFA,ISRAEL
[3] UNIV FLORIDA,DEPT PSYCHIAT,GAINESVILLE,FL 32611
关键词
panic disorder; generalized anxiety disorder; alprazolam; cortisol; catecholamine;
D O I
10.1111/j.1600-0447.1995.tb09604.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Thirty-six patients with panic disorder (PD) and 35 patients with generalized anxiety disorder (GAD) participated in an open alprazolam treatment phase that preceded controlled withdrawal from alprazolam. Clinical ratings, blood pressure and heart rate were obtained along with plasma measurements of cortisol, ACTH, growth hormone and catecholamines. A similar clinical response profile was evident in both groups with rapid onset of improvement within the first week. The two diagnostic groups differed in their biological response to alprazolam. PD patients had a significant reduction in blood pressure, plasma cortisol and a trend toward significant reduction in plasma epinephrine, which were not seen in the GAD patients. GAD patients showed a significant reduction in plasma norepinephrine. These findings provide further evidence that PD and GAD are biologically distinct syndromes.
引用
收藏
页码:399 / 408
页数:10
相关论文
共 50 条
  • [31] Alexithymia and Emotional Intelligence in Patients with Panic Disorder, Generalized Anxiety Disorder and Major Depressive Disorder
    Onur, Elif
    Alkin, Tunc
    Sheridan, Michael J.
    Wise, Thomas N.
    PSYCHIATRIC QUARTERLY, 2013, 84 (03) : 303 - 311
  • [32] Alexithymia and Emotional Intelligence in Patients with Panic Disorder, Generalized Anxiety Disorder and Major Depressive Disorder
    Elif Onur
    Tunc Alkın
    Michael J. Sheridan
    Thomas N. Wise
    Psychiatric Quarterly, 2013, 84 : 303 - 311
  • [33] Alexithymia and emotional intelligence in patients with panic disorder, generalized anxiety disorder and major depressive disorder
    Onur, E.
    Alkin, T.
    Sheridan, M.
    Cimilli, C.
    Wise, T. N.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008, 64 (06) : 666 - 666
  • [34] ALPRAZOLAM FOR PANIC DISORDER AND DEPRESSION
    PIES, R
    AMERICAN JOURNAL OF PSYCHIATRY, 1983, 140 (05): : 640 - 640
  • [35] Decreased hypothalamus volumes in generalized anxiety disorder but not in panic disorder
    Terlevic, Robert
    Isola, Miriam
    Ragogna, Maria
    Meduri, Martina
    Canalaz, Francesca
    Perini, Laura
    Rambaldelli, Gianluca
    Travan, Luciana
    Crivellato, Enrico
    Tognin, Stefania
    Como, Giuseppe
    Zuiani, Chiara
    Bazzocchi, Massimo
    Balestrieri, Matteo
    Brambilla, Paolo
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 146 (03) : 390 - 394
  • [36] DEPRESSION IN PANIC DISORDER AND RESPONSE TO ALPRAZOLAM THERAPY - REPLY
    LESSER, IM
    RUBIN, RT
    ARCHIVES OF GENERAL PSYCHIATRY, 1989, 46 (11) : 1053 - 1054
  • [37] RESPONSE OF PANIC DISORDER TO FIXED DOSES OF ALPRAZOLAM OR IMIPRAMINE
    UHLENHUTH, EH
    MATUZAS, W
    GLASS, RM
    EASTON, C
    JOURNAL OF AFFECTIVE DISORDERS, 1989, 17 (03) : 261 - 270
  • [38] Comparison of the course and prognosis of generalized anxiety disorder and panic disorder
    Woodman, CL
    Noyes, R
    Black, D
    Schlosser, S
    Yagla, SJ
    PSYCHOSOMATICS, 1996, 37 (02) : 38 - 38
  • [39] Developmental risk factors in generalized anxiety disorder and panic disorder
    Newman, Michelle G.
    Shin, Ki Eun
    Zuellig, Andrea R.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 206 : 94 - 102
  • [40] Differential attentional bias in generalized anxiety disorder and panic disorder
    Chen, Jing
    Wang, Zhiyan
    Wu, Yan
    Cai, Yiyun
    Shen, Yifeng
    Wang, Liwei
    Shi, Shenxun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 73 - 80